Navigation Links
Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
Date:5/8/2012

MINNEAPOLIS, May 8, 2012 /PRNewswire/ -- Coloplast North America today announced that a federal court jury in Tacoma, Wash., ruled that Generic Medical Devices, Inc. (GMD) was infringing on a Coloplast Urology Care patent for the transobturator (TOT) method for treating stress urinary incontinence in women. Using this approach, surgeons implant Coloplast's Aris® sling to help women regain control of their bladder.

The jury found that GMD infringed six separate claims of U.S. Patent Number 7,621,864, by marketing and selling its surgical tools and sling products for the purpose of using the TOT surgical method patented by Coloplast. The court soon will schedule a briefing on Coloplast's motion for a permanent injunction.

"By pursuing and winning this patent case, Coloplast is able to protect the research and development investments we make," said Steffen Hovard, senior vice president of Coloplast Urology Care. "Our mission is to improve patient quality of life. Protecting our patents allows us to realize that mission and push the industry forward through innovation. This is how we bring the best technologies, best devices and best methods to our surgeon partners and patients."

Coloplast was represented in the patent case by Faegre Baker Daniels LLP.

About Aris®

Aris® is a sling used to treat stress urinary incontinence in women. The Aris sling is implanted using the newest effective treatment approach, transobturator, which places the sling in a hammock position cradling the urethra. When in place, the sling supports and keeps the urethra in the correct position without the use of screws, anchors or sutures.

About Coloplast

Danish medical device company Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Coloplast's business includes ostomy care, urology, continence care, and wound and skin care. Coloplast operates globally and employs more than 7,500 people worldwide. In 2009, Coloplast opened the new North American headquarters in Minneapolis, Minnesota. The campus is LEED-certified (Leadership in Energy and Environmental Design) and is home to one of the company's three global research-and-development Innovation Centers. Others are located in Denmark and France.

To learn more about Coloplast, visit www.us.coloplast.com and www.straighttalk.net.


'/>"/>
SOURCE Coloplast
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
2. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
3. Broad Patent Protection Granted for iBio Immunomodulator
4. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
5. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
6. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
7. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
8. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
9. Essential Medical Dismisses Patent Case against Masimo and Cercacor
10. Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
11. Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary to popular perception, a ... declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found ... in the United States. The study, Trends in Fighting and Violence Among ...
(Date:4/21/2017)... ... April 21, 2017 , ... Dudnyk has announced the launch of its ... that the full potential of specialty and orphan brands can only be achieved when ... , “The Unifying Effect is at the heart of a true partnership between our ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry ... O2X , an active lifestyle company that provides Human Performance Training and education ... police offers, first responders, military officers and others in service through the development ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... in the category of International Trade, the UK’s most prestigious award for business ... which represents 95% of total revenues and has grown by a total of ...
(Date:4/21/2017)... ... April 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... in hopes of squashing a global crisis with solution to peace plan. Yisrayl says war ... because the plan is given by the Creator Himself. , Yisrayl says war drums ...
Breaking Medicine News(10 mins):